23/07/2015 - 18:57
WASHINGTON – An antiamyloid antibody that showed significant cognitive benefit at 10 mg/kg failed to deliver similar good news at a lower dose in the first randomized, antiamyloid antibody trial...
Field of Interest: Geriatrics
News Feed: Internal Medicine News - Geriatrics